<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00420862</url>
  </required_header>
  <id_info>
    <org_study_id>DANTE</org_study_id>
    <nct_id>NCT00420862</nct_id>
  </id_info>
  <brief_title>The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lega Italiana per la Lotta contro i Tumori</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <brief_summary>
    <textblock>
      High survival rates have been reported for screen-detected Stage I lung cancer patients, but&#xD;
      there are concerns about the potential biases of uncontrolled studies. DANTE is a prospective&#xD;
      randomized controlled trial exploring the effects of screening with LDCT on&#xD;
      lung-cancer-specific mortality, and on the prevalence and incidence rates of lung cancer,&#xD;
      stage distribution and resectability rates in a selected high-risk population. The prevalence&#xD;
      of a set of biomarkers in sputum and blood samples is also being determined.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>June 2001</start_date>
  <completion_date>February 2010</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>2400</enrollment>
  <condition>Lung Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spiral Computed Tomography</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male sex&#xD;
&#xD;
          -  Age 60-74 years&#xD;
&#xD;
          -  smokers of more than 20 cigarettes/day for at least 20 years (actual smokers or&#xD;
             ex-smokers from no more than 10 years)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe cardiopathy&#xD;
&#xD;
          -  advanced BPCO with chronic hypoxaemia (rest SatO2 &lt; 94%)&#xD;
&#xD;
          -  chronic severe renal insufficiency&#xD;
&#xD;
          -  hypertension not controlled with drugs&#xD;
&#xD;
          -  type 2 diabetes or other severe systemic disease&#xD;
&#xD;
          -  severe previous cerebrovascular lesions with permanent invalidity (not&#xD;
             self-sufficient).&#xD;
&#xD;
          -  severe vascular lesions with repeated ictus, trophic lesions, or limb loss, if actual&#xD;
             smoker&#xD;
&#xD;
          -  Dementia, psychosis, severe depression or maniac-depressive syndrome&#xD;
&#xD;
          -  actual or precedent neoplasia, excepted skin tumor not-melanoma or scaly cells&#xD;
             laryngeal and buccal cavity tumor, N0, recovered from more than 10 years or other&#xD;
             tumors recovered from more than 10 years&#xD;
&#xD;
          -  transplantation less than 5 years or with rejection episodes in the last 2 years&#xD;
&#xD;
          -  unable subjects&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianni Ravasi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Clinico Humanitas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <state>MI</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2007</verification_date>
  <study_first_submitted>January 10, 2007</study_first_submitted>
  <study_first_submitted_qc>January 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2007</study_first_posted>
  <last_update_submitted>January 10, 2007</last_update_submitted>
  <last_update_submitted_qc>January 10, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2007</last_update_posted>
  <keyword>Lung neoplasms</keyword>
  <keyword>Early diagnosis</keyword>
  <keyword>Screening</keyword>
  <keyword>Spiral Computed Tomography</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

